FDA Quality Assurance Will Catalogue CDER Initiatives To Improve Processes
The Center for Drug Evaluation & Research's quality assurance unit plans to catalogue different initiatives within the center to standardize and improve processes under newly appointed Associate Director for Quality Assurance Mark Goldberger, MD.
You may also be interested in...
FDA is seeking funding for employee retention bonuses as a way to stem the migration of competent FDA reviewers to more lucrative jobs in private companies, the agency said.
FDA is completing a change of the guard in the Office of Drug Evaluation II with the appointment of Reproductive & Urologic Drug Products Division Director Lisa Rarick, MD, as ODE II deputy director.
FDA Education and Outreach Director Mary Pat Couig and Policy & Programs Director Vicki Babb will manage MedWatch following the departure of Medical Director Stephen Goldman, MD, to Knoll Pharmaceuticals and Director Dianne Kennedy to the Office of Drug Evaluation IV (1"The Pink Sheet" Sept. 13, p. 3). FDA is searching for a permanent medical director and hopes to make that appointment before year-end